Safety issues of antiarrhythmic therapy for atrial fibrillation
The article discusses the safety of antiarrhythmic therapy for atrial fibrillation in the light of the development of cardiac and non-cardiac side effects, the presence of drug-drug interactions of antiarrhythmic drugs in the near (with anticoagulants) and far circle. The features of the choice of a...
Saved in:
Main Authors: | I.I. Reznik (Author), Ya.G. Bozhko (Author) |
---|---|
Format: | Book |
Published: |
LLC "MEDIAFORMAT",
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Present and future of antiarrhythmic therapy for atrial fibrillation: A review
by: Aida I. Tarzimanova
Published: (2024) -
Efficacy of class III antiarrhythmics and magnesium combination therapy for atrial fibrillation
by: Wang A
Published: (2012) -
ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016) -
ANTIARRHYTHMIC EFFICACY OF PROPAFENONE IN PATIENTS WITH PERSISTENT ATRIAL FIBRILLATION
by: R. D. Kurbanov, et al.
Published: (2016) -
CHANGES IN THE LEVEL OF NATRIURETIC PEPTIDES IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ANTIARRHYTHMIC DRUGS
by: V. I. Podzolkov, et al.
Published: (2015)